Groundbreaking technology by Hywel Dda University Health Board offers a new solution for pregnant women with Type 1 Diabetes to manage glucose levels effectively, reducing risks during pregnancy.

Women with Type 1 diabetes often have difficulties managing their glucose levels before and during pregnancy. However, reducing blood glucose levels before and during pregnancy has been shown to reduce the risk of serious adverse outcomes, including birth defects, stillbirth, and neonatal death.

Women who are already pregnant or are planning a pregnancy are being offered an ‘artificial pancreas’ which is made up of an insulin pump, a glucose sensor, and an advanced algorithm running on a mobile phone application.

The artificial pancreas will then calculate and deliver precise insulin dosages required before and during pregnancy.